Camille N. Abboud

6.2k total citations
109 papers, 2.7k citations indexed

About

Camille N. Abboud is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Camille N. Abboud has authored 109 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Hematology, 30 papers in Molecular Biology and 25 papers in Genetics. Recurrent topics in Camille N. Abboud's work include Acute Myeloid Leukemia Research (61 papers), Hematopoietic Stem Cell Transplantation (25 papers) and Multiple Myeloma Research and Treatments (22 papers). Camille N. Abboud is often cited by papers focused on Acute Myeloid Leukemia Research (61 papers), Hematopoietic Stem Cell Transplantation (25 papers) and Multiple Myeloma Research and Treatments (22 papers). Camille N. Abboud collaborates with scholars based in United States, Germany and Italy. Camille N. Abboud's co-authors include Jane L. Liesveld, John F. DiPersio, Geoffrey L. Uy, Ravi Vij, Peter Westervelt, Daniel H. Ryan, Keith Stockerl‐Goldstein, B L Nuccie, Michael P. Rettig and Amanda F. Cashen and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Camille N. Abboud

103 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Camille N. Abboud United States 27 1.6k 810 783 558 478 109 2.7k
Kensuke Usuki Japan 26 1.5k 0.9× 1.0k 1.3× 556 0.7× 638 1.1× 828 1.7× 160 3.1k
Valeria Visconte United States 29 1.8k 1.1× 1.4k 1.7× 406 0.5× 756 1.4× 860 1.8× 181 3.2k
Henrik Hjorth‐Hansen Norway 27 1.9k 1.2× 774 1.0× 859 1.1× 414 0.7× 937 2.0× 74 2.8k
RG Andrews United States 19 1.5k 0.9× 687 0.8× 527 0.7× 886 1.6× 453 0.9× 32 2.5k
AB Deisseroth United States 33 2.0k 1.3× 682 0.8× 838 1.1× 523 0.9× 683 1.4× 69 3.0k
Christoph Walz Germany 25 792 0.5× 650 0.8× 375 0.5× 466 0.8× 679 1.4× 70 2.1k
Shin Fujisawa Japan 27 1.1k 0.7× 380 0.5× 572 0.7× 293 0.5× 561 1.2× 182 2.2k
José A. García‐Marco Spain 29 744 0.5× 816 1.0× 589 0.8× 798 1.4× 1.5k 3.2× 88 2.6k
Danielle Sainty France 25 1.7k 1.0× 1.2k 1.5× 623 0.8× 1.2k 2.1× 578 1.2× 74 3.0k
CA Juttner Australia 17 1.6k 1.0× 363 0.4× 723 0.9× 697 1.2× 490 1.0× 28 2.2k

Countries citing papers authored by Camille N. Abboud

Since Specialization
Citations

This map shows the geographic impact of Camille N. Abboud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camille N. Abboud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camille N. Abboud more than expected).

Fields of papers citing papers by Camille N. Abboud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camille N. Abboud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camille N. Abboud. The network helps show where Camille N. Abboud may publish in the future.

Co-authorship network of co-authors of Camille N. Abboud

This figure shows the co-authorship network connecting the top 25 collaborators of Camille N. Abboud. A scholar is included among the top collaborators of Camille N. Abboud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camille N. Abboud. Camille N. Abboud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maris, Michael B., Gilles Salles, Won Seog Kim, et al.. (2024). ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study. Targeted Oncology. 19(3). 321–332. 4 indexed citations
2.
Choi, Jaebok, Matthew Cooper, Mark A. Fiala, et al.. (2023). Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 29(11). 699.e1–699.e9. 2 indexed citations
4.
Wang, Eunice S., Richard Aplenc, Deborah Chirnomas, et al.. (2020). Safety of gemtuzumab ozogamicin as monotherapy or combination therapy in an expanded-access protocol for patients with relapsed or refractory acute myeloid leukemia. Leukemia & lymphoma. 61(8). 1965–1973. 11 indexed citations
5.
Brümmendorf, Tim H., Carlo Gambacorti‐Passerini, Camille N. Abboud, et al.. (2019). Maintenance of Health-Related Quality of Life in the Phase 4 BYOND Study of Bosutinib for Pretreated Chronic Phase Chronic Myeloid Leukemia. Blood. 134(Supplement_1). 4157–4157. 1 indexed citations
6.
Ali, Alaa M., Feng Gao, Geoffrey L. Uy, et al.. (2017). Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10‐day decitabine regimen. Cancer Medicine. 6(12). 2814–2821. 21 indexed citations
7.
Lee, Yi-Shan, Jingxia Liu, Ravi Vij, et al.. (2017). Lack of a Prognostic Impact of the MyD88 L265P Mutation for Diffuse Large B Cell Lymphoma Patients Undergoing Autologous Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 23(12). 2199–2204. 7 indexed citations
8.
Ali, Alaa M., Erkin М Мirrakhimov, Camille N. Abboud, & Amanda F. Cashen. (2016). Leukostasis in adult acute hyperleukocytic leukemia: a clinician's digest. Hematological Oncology. 34(2). 69–78. 37 indexed citations
9.
Uy, Geoffrey L., Michael P. Rettig, Ibraheem Motabi, et al.. (2012). A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia. Blood. 119(17). 3917–3924. 310 indexed citations
10.
O’Brien, Susan, Camille N. Abboud, Mojtaba Akhtari, et al.. (2012). Chronic Myelogenous Leukemia. Journal of the National Comprehensive Cancer Network. 10(1). 64–110. 20 indexed citations
12.
Fehniger, Todd A., Geoffrey L. Uy, Kathryn Trinkaus, et al.. (2010). A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia. Blood. 117(6). 1828–1833. 82 indexed citations
13.
Ansstas, George, Waseem Touma, Camille Adeimy, et al.. (2010). Decitabine for Older AML Patients: An Effective Therapy Associated with Short Hospitalization and No Invasive Fungal Infection.. Blood. 116(21). 1063–1063.
14.
Phillips, Gordon L., Steven H. Bernstein, Jane L. Liesveld, et al.. (2010). A Phase I Trial: Dose Escalation of Melphalan in the “BEAM” Regimen Using Amifostine Cytoprotection. Biology of Blood and Marrow Transplantation. 17(7). 1033–1042. 6 indexed citations
15.
Liesveld, Jane L., et al.. (2001). Response of Human CD34 + Cells to CXC, CC, and CX 3 C Chemokines: Implications for Cell Migration and Activation. Journal of Hematotherapy & Stem Cell Research. 10(5). 643–655. 21 indexed citations
16.
Liesveld, Jane L., et al.. (2000). Effects of anti-oxidants on normal and leukemic hematopoiesis. Experimental Hematology. 28(7). 126–126. 1 indexed citations
17.
Liesveld, Jane L., et al.. (1995). Effect of stem cell factor on myelopoiesis potential in human Dexter-type culture systems.. PubMed. 23(3). 202–9. 10 indexed citations
18.
Liesveld, Jane L., Peter C. Keng, Jacob M. Rowe, John F. DiPersio, & Camille N. Abboud. (1994). Effects of GM-CSF on Ki67 expression and cell cycle traverse in acute myelogenous leukemia specimens and cell lines. Leukemia Research. 18(8). 609–616. 7 indexed citations
19.
Scott, Glynis, James F. Ewing, Daniel H. Ryan, & Camille N. Abboud. (1994). Stem Cell Factor Regulates Human Melanocyte‐Matrix Interactions. Pigment Cell Research. 7(1). 44–51. 40 indexed citations
20.
Liesveld, Jane L., Camille N. Abboud, R. John Looney, Daniel H. Ryan, & James K. Brennan. (1988). Expression of IgG Fc receptors in myeloid leukemic cell lines. Effect of colony-stimulating factors and cytokines.. The Journal of Immunology. 140(5). 1527–1533. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026